These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16565614)

  • 1. [Focal nodular hyperplasia of the liver: imaging findings with emphasis on the findings of superparamagnetic iron oxide-enhanced MR imaging].
    Han JK; Kim SH
    Korean J Hepatol; 2006 Mar; 12(1):116-9. PubMed ID: 16565614
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.
    Ba-Ssalamah A; Schima W; Schmook MT; Linnau KF; Schibany N; Helbich T; Reimer P; Laengle F; Wrba F; Kurtaran A; Ryan M; Mann FA
    AJR Am J Roentgenol; 2002 Dec; 179(6):1447-56. PubMed ID: 12438034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal nodular hyperplasia of the liver: usefulness of superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Okada T; Sasaki F; Kamiyama T; Nakagawa T; Nakanishi K; Kobayashi R; Itoh T; Ota S; Todo S
    J Pediatr Surg; 2005 Mar; 40(3):E21-5. PubMed ID: 15793708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
    Fröhlich JM
    J Magn Reson Imaging; 2004 Mar; 19(3):375-6; author reply 376. PubMed ID: 14994308
    [No Abstract]   [Full Text] [Related]  

  • 5. [The characterization value of feridex-enhanced MR imaging for focal hepatic lesions in reference to their histological pathology].
    Yang HF; Zhou XP; Yu JQ; Song B; Guang YS; Zhang HY; Chen X
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):548-50. PubMed ID: 16042902
    [No Abstract]   [Full Text] [Related]  

  • 6. Usefulness of power Doppler ultrasonography and superparamagnetic iron oxide enhanced magnetic resonance imaging for diagnosis of focal nodular hyperplasia of the liver after treatment of neuroblastoma.
    Sugito K; Kusafuka T; Kawashima H; Uekusa S; Furuya T; Ohashi K; Inoue M; Ikeda T; Koshinaga T; Maebayashi T
    Pediatr Hematol Oncol; 2010 Apr; 27(3):250-6. PubMed ID: 20367270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion study of liver lesions with superparamagnetic iron oxide: distinguishing hepatocellular carcinoma from focal nodular hyperplasia.
    Saito K; Sugimoto K; Nishio R; Araki Y; Moriyasu F; Kakizaki D; Tokuuye K
    Clin Imaging; 2009; 33(6):447-53. PubMed ID: 19857805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
    De Gaspari A; De Cobelli F; Del Maschio A
    Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
    Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A
    J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal nodular hyperplasia: intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging.
    Marin D; Iannaccone R; Laghi A; Catalano C; Murakami T; Hori M; Kim T; Passariello R
    J Magn Reson Imaging; 2007 Apr; 25(4):775-82. PubMed ID: 17348002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study.
    Terkivatan T; van den Bos IC; Hussain SM; Wielopolski PA; de Man RA; IJzermans JN
    J Magn Reson Imaging; 2006 Oct; 24(4):864-72. PubMed ID: 16947339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques.
    Zech CJ; Seiderer J; Reinisch W; Ochsenkuhn T; Schima W; Diebold J; Wrba F; Reiser MF; Schoenberg SO
    Eur Radiol; 2007 Jul; 17(7):1898-905. PubMed ID: 17221208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
    Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
    Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA.
    Kacl GM; Hagspiel KD; Marincek B
    Abdom Imaging; 1997; 22(3):264-7. PubMed ID: 9107647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging.
    Paley MR; Mergo PJ; Torres GM; Ros PR
    AJR Am J Roentgenol; 2000 Jul; 175(1):159-63. PubMed ID: 10882267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US.
    Hagspiel KD; Neidl KF; Eichenberger AC; Weder W; Marincek B
    Radiology; 1995 Aug; 196(2):471-8. PubMed ID: 7617863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review.
    Petersein J; Saini S; Weissleder R
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):53-60. PubMed ID: 8673716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in association with hepatic focal nodular hyperplasia.
    Langrehr JM; Pfitzmann R; Hermann M; Radke C; Neuhaus P; Pech M; Denecke T; Felix R; Hänninen EL
    Acta Radiol; 2006 May; 47(4):340-4. PubMed ID: 16739692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of SPIO particles for characterization of liver hemangiomas using MRI.
    Montet X; Lazeyras F; Howarth N; Mentha G; Rubbia-Brandt L; Becker CD; Vallee JP; Terrier F
    Abdom Imaging; 2004; 29(1):60-70. PubMed ID: 15160755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.